Atlas Venture Life Science Advisors, LLC Spero Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $341 Million
- Q1 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 305,255 shares of SPRO stock, worth $714,296. This represents 0.06% of its overall portfolio holdings.
Number of Shares
305,255
Previous 305,255
-0.0%
Holding current value
$714,296
Previous $317,000
30.91%
% of portfolio
0.06%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding SPRO
# of Institutions
44Shares Held
14.4MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX3.8MShares$8.89 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$4.13 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.17 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$2.27 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.08 Million0.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $82.1M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...